Experienced in Appendix Cancer

Yanhong C. Gu

300 Guangzhou Road, 
Nanjing, CN 
Experienced in Appendix Cancer
300 Guangzhou Road, 
Nanjing, CN 
OverviewLocationsClinical Research

Overview

Yanhong Gu practices in Nanjing, China. Gu is rated as an Experienced expert by MediFind in the treatment of Appendix Cancer. Their top areas of expertise are Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limbs Defects, Colorectal Cancer, Nonbullous Congenital Ichthyosiform Erythroderma, Abdominal Wall Surgery, and Gastrectomy.

Their clinical research consists of co-authoring 129 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Appendix Cancer.

Locations

300 Guangzhou Road, Nanjing, 210029, China
Other Locations
Jiangsu Province HospitalNo. 300 Guangzhou Road, Nanjing, 210029, China
140 Hanzhong Road, Nanjing, 210029, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Safety and Efficacy of Combination of Sintilimab and Platinum-based Chemotherapy in Neoadjuvant Treatment of Potentially Resectable Esophageal Cancer: An Open-lable, Single-arm, Exploratory Clinical Study
Safety and Efficacy of Combination of Sintilimab and Platinum-based Chemotherapy in Neoadjuvant Treatment of Potentially Resectable Esophageal Cancer: An Open-lable, Single-arm, Exploratory Clinical Study
Enrollment Status: Unknown
Publish Date: July 19, 2022
Intervention Type: Drug
Study Drugs: Sintilimab, Liposomal Paclitaxel + Cisplatin + S-1
Study Phase: Phase 2
A Single Arm, Open Label, Multicenter Exploratory Study of Apatinib in Patients With Metastatic Colorectal Cancer (CRC) Who Have Progressed After Standard Second Line Therapy
A Single Arm, Open Label, Multicenter Exploratory Study of Apatinib in Patients With Metastatic Colorectal Cancer (CRC) Who Have Progressed After Standard Second Line Therapy
Enrollment Status: Completed
Publish Date: January 14, 2020
Intervention Type: Drug
Study Phase: Phase 2
Andrographolides With or Without Capecitabine for Elderly Patients With Locally Advanced or Recurrent or Metastasis Inoperable Colorectal Cancer: a Randomized, Open-label Trial.
Andrographolides With or Without Capecitabine for Elderly Patients With Locally Advanced or Recurrent or Metastasis Inoperable Colorectal Cancer: a Randomized, Open-label Trial.
Enrollment Status: Terminated
Publish Date: January 14, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

129 Total Publications

Deep Learning Photo Processing for Periodontitis Screening.
Deep Learning Photo Processing for Periodontitis Screening.
Journal: Journal of dental research
Published: July 12, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Gu's expertise for a condition
ConditionClose
    View All 33 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile